Herpes simplex type 1 defective interfering particles do not affect the antiviral activity of acyclovir, foscarnet and adenine arabinoside
- PMID: 2899962
Herpes simplex type 1 defective interfering particles do not affect the antiviral activity of acyclovir, foscarnet and adenine arabinoside
Abstract
The concentration of defective interfering particles (DI-particles) of herpes simplex type 1 virus was analysed by electron microscopy and plaque titration. Fifteen consecutive passages of undiluted virus in green monkey kidney cells were followed. No relationship was found between the concentration of DI-particles and the activity of antiviral substances such as acyclovir, foscarnet and adenine arabinoside.
Similar articles
-
Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.Chemioterapia. 1987 Jun;6(2 Suppl):665-6. Chemioterapia. 1987. PMID: 2855616 No abstract available.
-
Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.N Engl J Med. 1989 Feb 2;320(5):297-300. doi: 10.1056/NEJM198902023200507. N Engl J Med. 1989. PMID: 2536137 No abstract available.
-
A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.N Engl J Med. 1991 Aug 22;325(8):551-5. doi: 10.1056/NEJM199108223250805. N Engl J Med. 1991. PMID: 1649971 Clinical Trial.
-
[Resistance of herpes simplex viruses to antiviral drugs].Pathol Biol (Paris). 1993 Feb;41(2):172-7. Pathol Biol (Paris). 1993. PMID: 8392160 Review. French.
-
[Future of antifungal and antiviral agents. 2. Antiviral agents. a. Anti-herpes agents].Nihon Rinsho. 1984 Mar;42(3):638-44. Nihon Rinsho. 1984. PMID: 6088840 Review. Japanese. No abstract available.